Citi reiterates a 'Sell' rating on Tenet Healthcare (NYSE: THC). Price target lowered from $5 to $2.

Citi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE